The neurological outcome in the patients with myasthenia gravis who underwent thymectomy via sternotomy and video-assisted thoracoscopic surgery (VATS)

Vesna Martić; Nebojša Marić; Vlado Cvijanović

doi:10.2298/VSP190715133M

Vesna Martić Military Medical Academy, Clinic for Neurology, Belgrade, Serbia
Nebojša Marić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Vlado Cvijanović University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia

DOI: https://doi.org/10.2298/VSP190715133M

Keywords: myasthenia gravis, thymectomy, sternotomy, surgery, thoracic, video-assisted, surgery, thoracic, procedures, treatment, outcome

Abstract

Background/Aim. Thymectomy is accepted in the surgical treatment of the patients with myasthenia gravis (MG). Earlier thymectomy via sternotomy has recently been replaced by video-assisted thoracoscopic surgery (VATS), which is less invasive. The aim of this study was to determine the effectiveness and reliability of the two methods of surgical removal of the thymus by comparing the neurological outcome in patients with MG. Methods. The study included 60 patients with MG who underwent thymectomy at the beginning of their treatment: 30 patients underwent thymectomy via sternotomy, and the remaining 30 patients via VATS. In order to evaluate the effects of these two operation techniques, we compared the data related directly to the operation – the number of postoperative hospital days, the incidence of postoperative complications, as well as the data related to the neurological monitoring of these patients: directly after the operation, one year after the surgery and up to three years after the surgery. Results. The data related to the immediate postoperative period indicate a significantly shorter hospitalization after the VATS thymectomy (p < 0.001), but the percentage of postoperative complications in both groups was the same (p = 0.381). Clinical deterioration in the first year after the operation showed a uniform distribution, regardless of the type of performed operation (p = 0.470). The number of performed rethymectomies in the group that underwent thymectomy via sternotomy vs. VATS was of borderline statistical significance (p = 0.054). Complete stable remission, as a confirmation that the thymic tissue was removed in its entirety, was observed in about 11% of the patients who underwent thymectomy. For other patients, clinical remission was maintained with anticholinesterase and immunosuppressive therapy. Conclusion. The shorter hospitalization time and faster postoperative recovery, with an equal clinical efficacy and aesthetic component, favors the VATS thymectomy compared to thymectomy via sternotomy as more acceptable in the surgical treatment of the patients with MG.

Author Biography

Vesna Martić, Military Medical Academy, Clinic for Neurology, Belgrade, Serbia

Nacelnik instituta za naucne informacije

References

Wilkins KB, Bulkley GB. Thymectomy in the integrated man-agement of myasthenia gravis. Adv Surg 1999; 32: 105‒33.

Kirschner PA. Alfred Blalock and thymectomy for myasthenia gravis. Ann Thorac Surg 1987; 43(3): 348‒9.

Beghi E, Antozzi C, Batocchi AP, Cornelio F, Cosi V, Evoli A, et al. Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. 1991. J Neurol Sci J 1991; 106(2): 213‒20.

Grob D. Course and management of myasthenia gravis. J Am Med Assoc 1953; 153(6): 529‒32.

Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurolo-gy 1976; 26(11): 1054–9.

Kirschner PA. The history of surgery of the thymus gland. Chest Surg Clin N Am 2000; 10(1): 153‒65, x.

Sugarbaker DJ. Thoracoscopy in the management of anterior mediastinal masses. Ann Thorac Surg 1993; 56(3): 653‒6.

Caronia FP, Arrigo E, Trovato S, Lo Monte AI, Cottone S, Sgalam-bro F, et al. Uniportal bilateral video-assisted sequential thora-coscopic extended thymectomy. J Vis Surg 2017; 3: 69.

Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971; 38(6): 497–537.

Fan L, Ma S, Yang Y, Yan Z, Li J, Li Z. Clinical differences of early and late-onset myasthenia gravis in 985 patients. Neurol Res 2019; 41(1): 45–51.

Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis. Neurology 2016; 87(4): 419–25.

Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clini-cal research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000; 55(1): 16–23.

Sussman J, Farrugia ME, Maddison P, Hill M, Leite MI, Hilton Jones D. Myasthenia gravis: Association of British Neurologist management guidelines. Prac Neurol 2015; 15(3): 199‒206.

Palace J, Newsom-Davis J, Lecky B. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology 1998; 50(6): 1778‒83.

Lo CM, Lu HI, Hsieh MJ, Lee SS, Chang JP. Thymectomy for myasthenia gravis: Video assisted versus transsternal. J Formos Med Assoc 2014; 113(10): 722‒6.

Chang PC, Chou SH, Kao EL, Cheng YJ, Chuang HY, Liu CK, et al. Bilateral video-assisted thoracoscopic thymectomy vs ex-tended transsternal thymectomy in myasthenia gravis: a pro-spective study. Eur Surg Res 2005; 37(4): 199‒203.

Zahid I, Sharif S, Routledge T, Scarci M. Video-assisted thoraco-scopic surgery or transsternal thymectomy in the treatment of myasthenia gravis? Interact Cardiovas Thorac Surg 2011; 12(1): 40–6.

Qi K, Wang B, Wang B, Zhang LB, Chu XY. Video-assisted tho-racoscopic surgery thymectomy versus open thymectomy in patients with myasthenia gravis: a meta-analysis. Acta Chir Belg 2016; 116(5): 282–8.